Woodstock Corp’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,285
| Closed | -$1.46M | – | 171 |
|
|
2023
Q2 | $1.46M | Hold |
14,285
| – | – | 0.17% | 86 |
|
|
2023
Q1 | $1.3M | Hold |
14,285
| – | – | 0.17% | 89 |
|
|
2022
Q4 | $543K | Sell |
14,285
-400
| -3% | -$13.8K | 0.07% | 112 |
|
|
2022
Q3 | $369K | Buy |
14,685
+1,212
| +9% | +$33.6K | 0.05% | 127 |
|
|
2022
Q2 | $409K | Hold |
13,473
| – | – | 0.06% | 127 |
|
|
2022
Q1 | $441K | Sell |
13,473
-664
| -5% | -$19.7K | 0.05% | 133 |
|
|
2021
Q4 | $373K | Sell |
14,137
-15,333
| -52% | -$1.19M | 0.04% | 152 |
|
|
2021
Q3 | $2.96M | Buy |
29,470
+1,840
| +7% | +$216K | 0.35% | 67 |
|
|
2021
Q2 | $3.91M | Buy |
27,630
+6,413
| +30% | +$724K | 0.46% | 62 |
|
|
2021
Q1 | $2.12M | Buy |
21,217
+150
| +0.7% | +$17.5K | 0.27% | 72 |
|
|
2020
Q4 | $2.6M | Sell |
21,067
-825
| -4% | -$108K | 0.35% | 67 |
|
|
2020
Q3 | $2.13M | Buy |
21,892
+6,783
| +45% | +$848K | 0.34% | 61 |
|
|
2020
Q2 | $2.36M | Hold |
15,109
| – | – | 0.4% | 60 |
|
|
2020
Q1 | $2.18M | Hold |
15,109
| – | – | 0.44% | 59 |
|
|
2019
Q4 | $3.09M | Sell |
15,109
-5,515
| -27% | -$1.01M | 0.5% | 57 |
|
|
2019
Q3 | $1.66M | Hold |
20,624
| – | – | 0.29% | 72 |
|
|
2019
Q2 | $1.95M | Hold |
20,624
| – | – | 0.34% | 69 |
|
|
2019
Q1 | $1.76M | Hold |
20,624
| – | – | 0.32% | 70 |
|
|
2018
Q4 | $1.16M | Hold |
20,624
| – | – | 0.23% | 81 |
|
|
2018
Q3 | $1.69M | Sell |
20,624
-3,106
| -13% | -$219K | 0.29% | 79 |
|
|
2018
Q2 | $830K | Buy |
23,730
+3,978
| +20% | +$121K | 0.15% | 100 |
|
|
2018
Q1 | $405K | Buy |
19,752
+4,636
| +31% | +$119K | 0.08% | 127 |
|
|
2017
Q4 | $428K | Buy |
+15,116
| New | +$422K | 0.08% | 123 |
|
Other funds holding RETA
Woodstock Corp's RETA Position: Q3 2023 in Review
Woodstock Corp sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 14,285 shares — an estimated $1.46M sold.
Woodstock Corp first reported a position in RETA in Q4 2017 and held it in 23 quarters. The position peaked at $3.91M in Q2 2021. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- Woodstock Corp reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Woodstock Corp sold 14,285 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.46M.
- Woodstock Corp first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2017 and held it in 23 quarters.
- Woodstock Corp's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $3.91M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on Woodstock Corp's 13F filing for Q3 2023, filed 10 Oct 2023.